For: | Saha A, Mukhopadhyay M, Paul S, Bera A, Bandyopadhyay T. Incidental diagnosis of medullary thyroid carcinoma due to persistently elevated procalcitonin in a patient with COVID-19 pneumonia: A case report. World J Clin Cases 2022; 10(20): 7171-7177 [PMID: 36051107 DOI: 10.12998/wjcc.v10.i20.7171] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v10/i20/7171.htm |
Number | Citing Articles |
1 |
Agnieszka Bronowicka-Szydełko, Maciej Rabczyński, Ilias Dumas, Żanna Fiodorenko-Dumas, Beata Wojtczak, Łukasz Kotyra, Irena Kustrzeba-Wójcicka, Łukasz Lewandowski, Beata Ponikowska, Aleksandra Kuzan, Joanna Kluz, Andrzej Gamian, Katarzyna Madziarska. State of Knowledge About Thyroid Cancers in the Era of COVID-19—A Narrative Review. Biomedicines 2024; 12(12): 2829 doi: 10.3390/biomedicines12122829
|
2 |
Bo Wang, Jie Huang, Li Chen. Management of medullary thyroid cancer based on variation of carcinoembryonic antigen and calcitonin. Frontiers in Endocrinology 2024; 15 doi: 10.3389/fendo.2024.1418657
|
3 |
Szymon Mućka, Grzegorz K. Jakubiak, Natalia Pawlas. Procalcitonin: Infection or Maybe Something More? Noninfectious Causes of Increased Serum Procalcitonin Concentration: Updated Knowledge. Life 2025; 15(3): 446 doi: 10.3390/life15030446
|